Skip to main content

Advertisement

Log in

Antibiotic resistance and resistance mechanism of Corynebacterium kroppenstedtii isolated from patients with mastadenitis

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

To investigate the antibiotic resistance and resistance mechanism of Corynebacterium kroppenstedtii (C. kroppenstedtii) isolated from patients with mastadenitis. Ninety C. kroppenstedtii clinical isolates were obtained from clinical specimens in 2018–2019. Species identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Antimicrobial susceptibility testing was performed by the broth microdilution method. The resistance genes were detected using PCR and DNA sequencing. The results of antimicrobial susceptibility testing indicated that the resistance rates of C. kroppenstedtii to erythromycin and clindamycin, ciprofloxacin, tetracycline, and trimethoprim-sulfamethoxazole were 88.9%, 88.9%, 67.8%, 62.2%, and 46.6%, respectively. None of the C. kroppenstedtii isolates was resistant to rifampicin, linezolid, vancomycin, or gentamicin. The gene of erm(X) was detected in all clindamycin and erythromycin-resistant strains. The gene of sul(1) and tet(W) were detected among all trimethoprim sulfamethoxazole-resistant strains and tetracycline-resistant strains, respectively. Furthermore, 1 or 2 amino acid mutations (mainly single mutation) were observed in the gyrA gene among ciprofloxacin-resistant strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data availability

The data analyzed were extracted from our hospital’s lab computer and the computerized patient records. The analysis was done transparently, and the database is available.

Materials availability

The data analyzed were extracted from our hospital’s lab computer and the computerized patient records. The analysis was done transparently, and the database is available.

Code availability

Not applicable.

References

  1. Tauch A, Fernández-Natal I, Soriano F (2016) A microbiological and clinical review on Corynebacterium kroppenstedtii. Int J Infect Dis 48:33–39

    Article  CAS  PubMed  Google Scholar 

  2. Collins MD, Falsen E, Akervall E, Sjöden B, Alvarez A (1998) Corynebacterium kroppenstedtii sp. nov., a novel corynebacterium that does not contain mycolic acids. Int J Syst Bacteriol 48(Pt 4):1449–1454

    Article  PubMed  Google Scholar 

  3. Johnstone KJ, Robson J, Cherian SG, Wan Sai Cheong J, Kerr K, Bligh JF (2017) Cystic neutrophilic granulomatous mastitis associated with Corynebacterium including Corynebacterium kroppenstedtii. Pathology 49(4):405–412

    Article  CAS  PubMed  Google Scholar 

  4. Yu HJ, Deng H, Ma J, Huang SJ, Yang JM, Huang YF et al (2016) Clinical metagenomic analysis of bacterial communities in breast abscesses of granulomatous mastitis. Int J Infect Dis 53:30–33

    Article  PubMed  Google Scholar 

  5. Co M, Cheng V, Wei J, Wong S, Chan S, Shek T et al (2018) Idiopathic granulomatous mastitis: a 10-year study from a multicentre clinical database. Pathology 50(7):742–747

    Article  PubMed  Google Scholar 

  6. Fernández-Natal I, Rodríguez-Lázaro D, Marrodán-Ciordia T, Sáez-Nieto JA, Valdezate S, Rodríguez-Pollán H et al (2016) Characterization and antimicrobial susceptibility of one antibiotic-sensitive and one multidrug-resistant Corynebacterium kroppenstedtii strain isolated from patients with granulomatous mastitis. New Microbes New Infect 14:93–97

    Article  PubMed  PubMed Central  Google Scholar 

  7. Poojary I, Kurian A, Jayalekshmi VA, Devapriya JD, Thirunarayan MA (2017) Corynebacterium species causing breast abscesses among patients attending a tertiary care hospital in Chennai, South India. Infect Dis (Lond) 49(7):528–531

    Article  CAS  PubMed  Google Scholar 

  8. Ersgaard H, Justesen T (1984) Multiresistant lipophilic corynebacteria from clinical specimens. Biochemical reactions and antimicrobial agents susceptibility. Acta Pathol Microbiol Immunol Scand B 92(1):39–43

    CAS  PubMed  Google Scholar 

  9. Weiss K, Laverdière M, Rivest R (1996) Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods. Antimicrob Agents Chemother 40(4):930–933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Martínez-Martínez L, Ortega MC, Suárez AI (1995) Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria. J Clin Microbiol 33(5):1318–1321

    Article  PubMed  PubMed Central  Google Scholar 

  11. Bao R, Gao X, Hu B, Zhou Z (2017) Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a powerful tool for identification of Corynebacterium species. J Thorac Dis 9(9):3239–3245

    Article  PubMed  PubMed Central  Google Scholar 

  12. Alibi S, Ferjani A, Boukadida J, Ruiz de Alegría C, Martínez-Martínez L, Navas J (2017) Evaluation of the VITEK-MS matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of clinical Corynebacterium species. Rev Esp Quimioter 30(1):57–58

    CAS  PubMed  Google Scholar 

  13. Szemraj M, Kwaszewska A, Szewczyk EM (2018) New gene responsible for resistance of clinical Corynebacteria to macrolide, lincosamide and streptogramin B. Pol J Microbiol 67(2):237–240

    Article  PubMed  PubMed Central  Google Scholar 

  14. Alibi S, Ferjani A, Boukadida J, Cano ME, Fernández-Martínez M, Martínez-Martínez L et al (2017) Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital. Sci Rep 7(1):9704

    Article  PubMed  PubMed Central  Google Scholar 

  15. Fernández-Natal MI, Soriano F, Ariza-Miguel J, Marrodan-Ciordia T, Acedo A, Metal H (2015) Draft genome sequences of Corynebacterium kroppenstedtii CNM633/14 and CNM632/14, multidrug-resistant and antibiotic-sensitive isolates from nodules of granulomatous mastitis patients. Genome Announc c3(3):e00525–e00515

    Google Scholar 

  16. Sierra JM, Martinez-Martinez L, Vázquez F, Giralt E, Vila J (2005) Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum. Antimicrob Agents Chemother 49(5):1714–1719

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ramos JN, Valadão TB, Baio P, Mattos-Guaraldi AL, Vieira VV (2020) Novel mutations in the QRDR region gyrA gene in multidrug-resistance Corynebacterium spp. isolates from intravenous sites. Antonie Van Leeuwenhoek 4:589–592

    Article  Google Scholar 

Download references

Funding

This work was funded by the National Key Research and Development Program of China (2021YFC2701800 and 2021YFC2701803), the National Natural Science Foundation of China (grant no. 81861138052), the China Antimicrobial Surveillance Network (independent medical grants from Pfizer, 2018QD100), and the Shanghai Antimicrobial Surveillance Network (3030231003). The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.

Author information

Authors and Affiliations

Authors

Contributions

The study’s conception and design were prepared by Qin Zhang, Jian Xu, and Fupin Hu. Materials were prepared by Qin Zhang, Peipei Song, Yi Liu, Xuan Zhu, Liyuan Zhang, Jun Zhang, Qin Wang, and Jian Xu. Experimentation, data collection, and analysis were performed by Qin Zhang, Shi Wu, Li Ding, and Qingyu Shi. The first draft of the manuscript was written by Qin Zhang, Jian Xu, and Fupin Hu, and the manuscript was reviewed and edited by Fupin Hu. All the authors approved the final manuscript.

Corresponding authors

Correspondence to Jian Xu or Fupin Hu.

Ethics declarations

Ethics approval

This study was reviewed and approved by the Ethics Committee of Chengdu Women’s and Children’s Central Hospital. Informed consent from patients was not required by the Ethics Committee because there was no contact with patients.

Consent to participate

Informed consent from patients was not required by the Ethics Committee.

Consent for publication

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Q., Wu, S., Song, P. et al. Antibiotic resistance and resistance mechanism of Corynebacterium kroppenstedtii isolated from patients with mastadenitis. Eur J Clin Microbiol Infect Dis 42, 525–528 (2023). https://doi.org/10.1007/s10096-023-04558-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-023-04558-0

Keywords

Navigation